PAM-13 in clinical cancer care: A systematic review

IF 4.7 3区医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL

Archives of Medical Research Pub Date : 2024-12-19 DOI:10.1016/j.arcmed.2024.103145

Kenzy Jean Pierre , Elise Verot , Wafa Bouleftour

{"title":"PAM-13 in clinical cancer care: A systematic review","authors":"Kenzy Jean Pierre , Elise Verot , Wafa Bouleftour","doi":"10.1016/j.arcmed.2024.103145","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The Patient Activation Measure-13 (PAM-13) assesses patients’ ability to manage their healthcare. This systematic review aimed to summarize the relationship between the PAM-13 and patient characteristics, as well as program effectiveness.</div></div><div><h3>Methods</h3><div>A systematic literature search was conducted using the PubMed database and following the PRISMA guidelines. After screening and selection processes, a total of 21 articles were included for analysis.</div></div><div><h3>Results</h3><div>Half of single cancer type studies have been conducted on breast cancer. In terms of impact on the PAM-13 score, non-digital programs (75%) demonstrated higher efficacy in cancer care compared to digital ones (14.29%). Patient characteristics, including education, fear of recurrence, and time spent with healthcare providers, influenced activation levels.</div></div><div><h3>Conclusion</h3><div>This systematic review provides insights into the association of PAM-13 with patient characteristics and program effectiveness in clinical cancer care. Future research should validate interventions using PAM-13 and improve digital initiatives to optimize cancer care outcomes.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"56 3","pages":"Article 103145"},"PeriodicalIF":4.7000,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Medical Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0188440924001966","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background

The Patient Activation Measure-13 (PAM-13) assesses patients’ ability to manage their healthcare. This systematic review aimed to summarize the relationship between the PAM-13 and patient characteristics, as well as program effectiveness.

Methods

A systematic literature search was conducted using the PubMed database and following the PRISMA guidelines. After screening and selection processes, a total of 21 articles were included for analysis.

Results

Half of single cancer type studies have been conducted on breast cancer. In terms of impact on the PAM-13 score, non-digital programs (75%) demonstrated higher efficacy in cancer care compared to digital ones (14.29%). Patient characteristics, including education, fear of recurrence, and time spent with healthcare providers, influenced activation levels.

Conclusion

This systematic review provides insights into the association of PAM-13 with patient characteristics and program effectiveness in clinical cancer care. Future research should validate interventions using PAM-13 and improve digital initiatives to optimize cancer care outcomes.

查看原文本刊更多论文

PAM-13在临床癌症治疗中的应用：系统综述。

背景：患者激活测量-13 （PAM-13）评估患者管理其医疗保健的能力。本系统综述旨在总结PAM-13与患者特征以及项目有效性之间的关系。方法：使用PubMed数据库并按照PRISMA指南进行系统的文献检索。经过筛选和选择过程，共纳入21篇文章进行分析。结果：一半的单一癌症类型研究都是针对乳腺癌进行的。在对PAM-13评分的影响方面，非数字化项目（75%）在癌症治疗方面表现出比数字化项目（14.29%）更高的疗效。患者的特征，包括教育程度、对复发的恐惧以及与医疗保健提供者相处的时间，都会影响激活水平。结论：本系统综述提供了PAM-13与患者特征和临床癌症治疗方案有效性之间的关系。未来的研究应该验证使用PAM-13的干预措施，并改进数字计划，以优化癌症治疗结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Archives of Medical Research 医学-医学：研究与实验

CiteScore

12.50

自引率

0.00%

发文量

审稿时长

28 days

期刊介绍： Archives of Medical Research serves as a platform for publishing original peer-reviewed medical research, aiming to bridge gaps created by medical specialization. The journal covers three main categories - biomedical, clinical, and epidemiological contributions, along with review articles and preliminary communications. With an international scope, it presents the study of diseases from diverse perspectives, offering the medical community original investigations ranging from molecular biology to clinical epidemiology in a single publication.